Israel-based AI-driven cancer diagnostics company Ibex Medical Analytics has raised USD 55 million in a Series C funding round led by 83North, with participation from Sienna Venture Capital and Octopus Ventures, among others. This brings the company's total funds raised to date to exceed USD 100 million.
The funding will be used to expand Ibex's presence in the US and grow its product portfolio. The company aims to meet the demand for AI-powered diagnostic solutions and support the digital transformation of pathologists and labs.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.